Skip to main content

Cassandra L. Paolillo

(she/her/hers)

Of Counsel

[email protected]

+1.617.348.1828

Share:

Cassie’s practice primarily involves advising health care clients on transactional and regulatory matters, including serving as regulatory counsel on health care transactions and assisting clients in establishing and implementing MSO-PC arrangements. She frequently oversees the health care regulatory aspects of complex transactions in the health care industry, including recent private equity investments in pediatric, dental, ambulatory surgery, and addiction treatment providers. She has also served as regulatory counsel to various institutional lenders in financing transactions in connection with the acquisition of health and life science industry companies. Cassie regularly acts as a subject matter expert, advising clients on HIPAA/privacy compliance, telehealth and other digital health matters, corporate practice issues, professional and facility licensing, determinations of need/certificates of need, and Medicare and Medicaid compliance. Cassie also has experience advising non-profit organizations on matters related to formation and corporate governance. 

Throughout her career, Cassie has worked with providers, payors, individual patients, and a range of investors in the health care space, so she understands the unique challenges facing clients in the ever-changing health care landscape. She enjoys working with interdisciplinary teams to come up with creative solutions to her clients’ problems. 

Prior to joining Mintz, Cassie worked as in-house counsel at a national senior living company. There she advised the business on matters related to state and federal health care regulations, physician arrangements, reimbursement, fraud and abuse, and HIPAA/privacy. Cassie’s in-house experience informs current her practice, enabling her to anticipate and relate to clients’ legal and business needs.

A member of the firm’s Pro Bono Committee, Cassie is particularly passionate about addressing health disparities, focusing on increasing access to reproductive health care and behavioral health services, including substance use disorder treatment. She currently serves on the Board of the South Boston Collaborative Center, a substance abuse and mental health treatment center located in South Boston.

viewpoints

Last week, President Trump signed an “Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First.” The order, which “seeks to enhance the ability of patients to choose the healthcare that is best for them,” includes a number of provisions requiring the Departments of Health and Human Services, Labor, Treasury and others to pass regulations to increase transparency for patients. The following is a summary of the executive order and a brief overview of what providers and others in the healthcare industry can anticipate going forward.
Read more
Last week, Mintz and ML Strategies welcomed stakeholders and thought leaders from across the pharmacy and pharmaceutical industry to the Boston Office for the 4th Annual Pharmacy & Pharmaceutical Industry Summit.
Read more
Last week, a U.S. district court judge in the Southern District of Florida upheld a magistrate judge’s decision to dismiss False Claims Act (FCA) allegations against a compounding pharmacy, its private equity firm owner, and two individuals. DOJ filed its complaint in intervention last February against the pharmacy, Patient Care America (PCA); its private equity backer, Riordan Lewis & Haden, Inc.; and two individual executives. The government alleged that the parties engaged in an illegal kickback scheme that resulted in the submission of false claims to TRICARE for expensive compounded drugs. This case is reportedly the first in which the federal government intervened against a private equity firm owner.
Read more

Independent Laboratory Settles Medical Necessity Allegations

February 20, 2019 | Blog | By Karen Lovitch, Cassandra Paolillo

The Department of Justice (DOJ) recently announced a $1.99 million False Claims Act (FCA) settlement with GenomeDx Biosciences Corp. (“GenomeDx”), a laboratory headquartered in Vancouver, British Columbia with operations in San Diego. The matter arose as the result of a qui tam case brought by two former employees in September 2017.
Read more

OIG Advisory Opinion Allows Routine Waiver of Federal Cost-Sharing Obligations

January 18, 2019 | Blog | By Karen Lovitch, Cassandra Paolillo

In an Advisory Opinion posted earlier this week, the OIG gave the green light to a charitable pediatric clinic’s routine waiver of patient cost-sharing amounts on the basis.  The OIG’s analysis hinged on several factors that, taken together, led the OIG to refrain from exercising its enforcement discretion.
Read more
As the year draws to a close, it’s clear that 2018 was another record year for private equity investment in health care.  In its report on the top health industry issues of 2019, PWC’s Healthcare Research Institute recently highlighted the continued prevalence of private equity in health care transactions, and predicted even more private equity investment in the coming year. Below is an overview of the current and expected trends, as well as a few key considerations for private equity deals in the health care space.
Read more

HPC Weighs in on Impact of Question 1

November 1, 2018 | Advisory | By Elissa Flynn-Poppey, Cassandra Paolillo, Stephen Weiner

This article discusses a Massachusetts Health Policy Commission report on the impact of Questions 1, the proposed Nurse Staffing Ratio Mandate.
Read more

Massachusetts HPC Health Care Cost Trends Hearing: Key Takeaways

October 24, 2018 | Blog | By Daria Niewenhous, Caitlin Beresin, Cassandra Paolillo

The Massachusetts Health Policy Commission (“HPC”) held its annual Health Care Cost Trends Hearing on October 16-17, 2018. The hearing covered a wide range of topics affecting the health care industry here in the Commonwealth and across the country. Here are some key takeaways and a legislative outlook.
Read more
The final bipartisan opioid package, which passed in the Senate this week and is expected to be signed into law, includes a significant revision from the original House bill that could lead to an increase in treatment options for Medicaid beneficiaries suffering from substance use disorder (“SUD”). The final version of the “SUPPORT for Patients and Communities Act” will provide state Medicaid programs with the option to cover SUD treatment in certain Institutions for Mental Diseases (“IMD”) for Medicaid beneficiaries between the ages of 21 and 64.
Read more
The Children’s Health Insurance Program (“CHIP”), created in 1997, helps states provide health care coverage to low-income children up to age 19 whose families fall above the Medicaid eligibility threshold but are unable to afford private insurance.
Read more
Read less

News & Press

Press Release Thumbnail Mintz

Mintz is pleased to announce that 31 attorneys have been named Massachusetts Super Lawyers and 35 attorneys have been named Massachusetts Rising Stars for 2024.

Press Release Thumbnail Mintz

187 Mintz attorneys have been recognized by Best Lawyers® in the 2025 edition of The Best Lawyers in America©. Notably, three Mintz attorneys received 2025 “Lawyer of the Year” awards, and 64 firm attorneys were included in the 2025 edition of Best Lawyers: Ones to Watch.

Press Release Thumbnail Mintz

Mintz is pleased to share that Member Natalie Groot and Of Counsel Cassandra Paolillo have been selected by Massachusetts Lawyers Weekly as 2024 Excellence in Law ‘Up & Coming Lawyer’ honorees.

Press Release Thumbnail Mintz

Mintz is pleased to announce that 32 attorneys have been named Massachusetts Super Lawyers and 27 attorneys have been named Massachusetts Rising Stars for 2023.

Press Release Thumbnail Mintz

Mintz is pleased to announce that 120 firm attorneys have been recognized as leaders by Best Lawyers® in the 2024 edition of The Best Lawyers in America©.

Press Release Thumbnail Mintz

35 Mintz attorneys have been named Massachusetts Super Lawyers and 25 Mintz attorneys have been named Massachusetts Rising Stars for 2022.

Read less

Events & Speaking

Speaker
Apr
4
2023

Tracking Technologies in Health Care

Women Business Leaders of the U.S. Health Care Industry Foundation

Online Event

Webinar Reference Image
Panelist
Dec
1
2020

Telehealth: What's Next?

Women Business Leaders of the U.S. Health Care Industry Foundation (WBL) Event

Online Event

Webinar Reference Image
Read less

Recognition & Awards

  • Best Lawyers in America: Ones to Watch - Health Care Law (2024, 2025)

  • Massachusetts Super Lawyers Rising Stars: Health Care (2022 – 2024)

  • Massachusetts Lawyers Weekly: Up & Coming Lawyer (2024)

Read less

Involvement

  • Member, American Health Law Association
  • Member, Boston Bar Association
  • Board Member, South Boston Collaborative Center
Read less

Cassandra L. Paolillo

(she/her/hers)

Of Counsel

Boston